Medical risk factors for severe West Nile virus disease, United States, 2008-2010

American Journal of Tropical Medicine and Hygiene

Volumn 87, Issue 1, 2012, Pages 179-184

  Lindsey, Nicole P ^a   Staples, J Erin ^a   Lehman, Jennifer A ^a   Fischer, Marc ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; CHRONIC KIDNEY DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; ENCEPHALITIS; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENINGITIS; RISK; RISK FACTOR; UNITED STATES; WEST NILE FEVER;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; UNITED STATES; WEST NILE FEVER;

WEST NILE VIRUS;

EID: 84863756875     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2012.12-0113     Document Type: Article

References (20)

1. Nash D, Mostashari F, Fine A, Miller J, O'Leary D, Murray K, Huang A, Rosenberg A, Greenberg A, Sherman M, Wong S, Layton M, 1999. West Nile Outbreak Response Working Group, 2001. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344: 1807-1814. (Pubitemid 32538693)
2. Reimann CA, Hayes EB, DiGuiseppi C, Hoffman R, Lehman JA, Lindsey NP, Campbell GL, Fischer M, 2008. Epidemiology of neuroinvasive arboviral disease-United States, 1999-2007. Am J Trop Med Hyg 79: 974-979.
3. Lindsey NP, Staples JE, Lehman JA, Fischer M, 2010. Surveillance for West Nile Virus disease-United States, 1999-2008. MMWR Surveill Summ 59: 1-17.
4. Centers for Disease Control and Prevention, 2010. West Nile virus activity-United States, 2009. MMWR Morb Mortal Wkly Rep 59: 769-772.
5. Patnaik JL, Harmon H, Vogt RL, 2006. Follow-up of 2003 human West Nile virus infections, Denver, Colorado. Emerg Infect Dis 12: 1129-1131. (Pubitemid 44061285)
6. Jean CM, Honarmand S, Louie JK, Glaser CA, 2007. Risk factors for West Nile virus neuroinvasive disease, California, 2005. Emerg Infect Dis 13: 1918-1920. (Pubitemid 350248498)
7. Murray K, Baraniuk S, Resnick M, Arafat R, Kilborn C, Cain K, Shallenberger R, York TL, Martinez D, Hellums JS, Hellums D, Malkoff M, Elgawley N, McNeely W, Khuwaja SA, Tesh RB, 2006. Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect 134: 1325-1332. (Pubitemid 44614956)
8. Lindsey NP, Hayes EB, Staples JE, Fischer M, 2009. West Nile Virus in children, United States, 1999-2007. Pediatrics 123: e1084-e1089.
9. Nett RJ, Kuehnert MJ, Ison MG, Orlowski JP, Fischer M, Staples JE, 2012. Current practices and evaluation of screening solid organ donors forWest Nile virus. Transpl InfectDis 14: 268-277.
10. Kumar D, Prasad GV, Zaltzman J, Levy GA, Humar A, 2004. Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation 77: 399-402. (Pubitemid 38209739)
11. Freifeld AG, Meza J, Schweitzer B, Shafer L, Kalil AC, Sambol AR, 2010. Seroprevalence of West Nile virus infection in solid organ transplant recipients. Transpl Infect Dis 12: 120-126.
12. Guarner J, Shieh WJ, Hunter S, Paddock CD, Morken T, Campbell GL, Marfin AA, Zaki SR, 2004. Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis. Hum Pathol 35: 983-990. (Pubitemid 39037181)
13. Han LL, Popovici F, Alexander JP Jr, Laurentia V, Tengelsen LA, Cernescu C, Gary HE Jr, Ion-Nedelcu N, Campbell GL, Tsai TF, 1999. Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996. J Infect Dis 179: 230-233. (Pubitemid 29028360)
14. Bode AV, Sejvar JJ, Pape WJ, Campbell GL, Marfin AA, 2006. West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clin Infect Dis 42: 1234-1240.
15. Chowers MY, Lang R, Nassar F, Ben-David D, Giladi M, Rubinshtein E, Itzhaki A, Mishal J, Siegman-Igra Y, Kitzes R, Pick N, Landau Z, Wolf D, Bin H, Mendelson E, Pitlik SD, Weinberger M, 2001. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis 7: 675-678. (Pubitemid 32845258)
16. Mazurek JM, Winpisinger K, Mattson BJ, Duffy R, Moolenaar RL, 2005. The epidemiology and early clinical features of West Nile virus infection. Am J Emerg Med 23: 536-543. (Pubitemid 41008009)
17. Centers for Disease Control and Prevention, 2011. Case Definitions for Infectious Conditions Under PublicHealth Surveillance: Neuroinvasive and Non-Neuroinvasive Domestic Arboviral Diseases, 2004.Available at: http://www.cdc.gov/osels/ph-surveillance/nndss/casedef/arboviral-2004.htm. Accessed November 1, 2011.
18. Rockhill B, Newman B, Weinberg C, 1998. The use and misuse of population attributable fractions. Am J Public Health 88: 15-19.
19. Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ, 2002. West Nile virus. Lancet 2: 519-529. (Pubitemid 34966355)
20. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, Fleischauer A, Leis AA, Stokic DS, Petersen LR, 2003. Neurologic manifestations and outcome of West Nile virus infection. JAMA 290: 511-515. (Pubitemid 37430505)